ZJYLNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends September 30
Jin Medical International Ltd.
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Feb 10, 2026
$2.11+0.03 (+1.44%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 10.5
- Dividend yield
- –
Jin Medical International statistics
Financials through Mar 31, 2026, price as of Oct 19, 2026, median of Orthopedic, Prosthetic & Surgical Appliances & Supplies companies for comparison
Valuation
| Measure | Jin Medical International | Industry median |
|---|---|---|
| Market Cap | $330.31M | $230.55M |
| Enterprise Value | $320.89M | $202.97M |
| PE Ratio | 10.55 | 31.60 |
| PS Ratio | 15.97 | 3.10 |
| PB Ratio | 10.89 | 3.04 |
| P/TBV Ratio | 11.31 | 4.43 |
| P/OCF Ratio | 113.76 | 22.47 |
Enterprise value
| Measure | Jin Medical International | Industry median |
|---|---|---|
| EV / Sales | 15.51 | 2.91 |
| EV / EBITDA | 376.81 | 19.74 |
| EV / EBIT | 527.62 | 24.80 |
Income (trailing twelve months)
| Measure | Jin Medical International | Industry median |
|---|---|---|
| Revenue | $20.69M | $102.39M |
| Gross Profit | $6.04M | $60.36M |
| Operating Income | $608.18K | -$4.31M |
| Pretax Income | $1.60M | -$2.37M |
| Net Income | $1.19M | -$6.57M |
| EBITDA | $851.59K | -$1.98M |
| EPS (Diluted) | $0.20 | -$0.08 |
Margins
| Measure | Jin Medical International | Industry median |
|---|---|---|
| Gross Margin | 29.2% | 55.2% |
| Operating Margin | 2.94% | -6.04% |
| Pretax Margin | 7.71% | -4.11% |
| Profit Margin | 5.76% | -10.5% |
| EBITDA Margin | 4.12% | -2.67% |
| FCF Margin | -18.0% | 0.02% |
Returns
| Measure | Jin Medical International | Industry median |
|---|---|---|
| Return on Equity (ROE) | 4.09% | -18.2% |
| Return on Assets (ROA) | 2.28% | -13.3% |
| Return on Invested Capital (ROIC) | 3.12% | -3.69% |
| Return on Capital Employed (ROCE) | 1.84% | -9.07% |
Growth
| Measure | Jin Medical International | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -12.0% | 8.85% |
| Net Income Growth (YoY) | -67.6% | 10.5% |
| EPS Growth (YoY) | -50.0% | 10.6% |
| Revenue Growth (3Y CAGR) | 2.53% | 7.08% |
| EPS Growth (3Y CAGR) | -20.6% | 3.11% |
Balance sheet
| Measure | Jin Medical International | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $30.10M | $36.66M |
| Total Debt | $20.85M | $97.65M |
| Net Cash (Debt) | $9.26M | $3.92M |
| Net Cash Per Share | $0.06 | $0.28 |
| Equity (Book Value) | $30.32M | $55.33M |
| Book Value Per Share | $0.19 | $2.87 |
| Tangible Book Value | $29.20M | $10.79M |
| Working Capital | $21.73M | $56.72M |
Financial position
| Measure | Jin Medical International | Industry median |
|---|---|---|
| Current Ratio | 1.95 | 2.48 |
| Quick Ratio | 1.56 | 1.53 |
| Debt / Equity | 0.69 | 0.41 |
| Debt / EBITDA | 24.48 | 2.40 |
| Net Debt / EBITDA | -10.87 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Jin Medical International | Industry median |
|---|---|---|
| Operating Cash Flow | $2.90M | -$566.22K |
| Capital Expenditures | -$6.63M | -$3.69M |
| Free Cash Flow | -$3.73M | -$696.00K |
| FCF Per Share | -$0.02 | -$0.02 |
Efficiency
| Measure | Jin Medical International | Industry median |
|---|---|---|
| Asset Turnover | 0.40 | 0.58 |
| Inventory Turnover | 2.87 | 2.21 |
| Revenue Per Employee | $517.18K | $322.92K |
| Profits Per Employee | $29.78K | -$51.88K |
| Employee Count | 40 | 185 |
Dividends and yields
| Measure | Jin Medical International | Industry median |
|---|---|---|
| Earnings Yield | 0.36% | -6.88% |
| FCF Yield | -1.13% | -0.45% |
Shares
| Measure | Jin Medical International | Industry median |
|---|---|---|
| Shares Outstanding | 156,547,000 | 44,302,700 |
| Shares Change (YoY) | 0.05% | 3.36% |
| Float | 143,538,000 | 37,462,700 |
| Shares Held by Insiders | 8.31% | 10.5% |
Taxes
| Measure | Jin Medical International | Industry median |
|---|---|---|
| Income Tax | $214.57K | $1.52M |
| Effective Tax Rate | 13.4% | 18.5% |
Scores
| Measure | Jin Medical International | Industry median |
|---|---|---|
| Graham Number | $0.93 | $35.97 |
| Graham Upside | -55.8% | -57.0% |
| Altman Z-Score | 9.11 | 1.95 |
| Piotroski F-Score | 4 | 5 |
Calculated by StockData from Jin Medical International's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.